Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.44    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.445
Spread: 0.015 (0.617%)
Market Cap: $8.05b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Annual Financial Report

6 Apr 2017 07:00

RNS Number : 6999B
Commercial Intnl Bank (Egypt) SAE
06 April 2017
 

 

Commercial International Bank (Egypt) S.A.E.

Consolidated IFRS Financial Statements

December 31, 2016

Consolidated statement of profit or loss for the year ended December 31, 2016

Notes

Dec. 31, 2016

Dec. 31, 2015

EGP Thousands

EGP Thousands

Interest and similar income

19,144,218

14,765,337

Interest and similar expense

(9,127,195)

(6,651,056)

Net interest income

3

10,017,023

8,114,281

Fee and commission income

1,965,529

1,932,054

Fee and commission expense

(417,573)

(299,696)

Net fee and commission income

4

1,547,956

1,632,358

Dividend income

5

34,236

35,062

Net trading income

6

1,315,182

710,398

Profits (Losses) on financial investments

22

(25,533)

270,998

Goodwill impairment

40

(217,078)

-

Administrative expenses

7

(3,119,378)

(2,561,964)

Other operating expenses

8

(1,233,620)

(566,304)

Impairment charge for credit losses

9

(892,874)

(1,682,439)

Bank's share in the profits of associates

12

2,989

27,829

Profit before income tax from continuing operations

7,428,903

5,980,219

Current income tax expense

(2,017,034)

(1,949,694)

Deferred income tax

10.2

(76,849)

136,047

Net profit from continuing operations

5,335,020

4,166,572

Discontinuing Operations

Profit from discontinuing operations (Net of tax)

39

127,376

61,115

Net profit for the year

5,462,396

4,227,687

Attributable to:

Equity holders of the parent

5,448,248

4,227,001

Non-controlling interest

14,148

686

Net Profit for the year

5,462,396

4,227,687

Earnings per share

11

Basic attributable to equity holders of the parent

4.72

3.69

Diluted attributable to equity holders of the parent

4.65

3.64

Earnings per share from continuing operations

Basic attributable to equity holders of the parent

4.61

3.63

Diluted attributable to equity holders of the parent

4.55

3.58

The  accompanying  notes from 1 to 41 form an integral part of these consolidated financial statements.

 

Consolidated statement of other comprehensive income for the year ended December 31, 2016

Notes

Dec. 31, 2016

Dec. 31, 2015

EGP Thousands

EGP Thousands

Profit for the year

5,462,396

4,227,687

Other comprehensive income

Other comprehensive income to be reclassified to profit or loss in subsequent periods:

Net (Loss)/gain on available-for-sale financial assets

22,219

(1,609,226)

Cumulative foreign currencies translation differences

32

8,588

-

Other comprehensive income for the year

30,807

(1,609,226)

Total comprehensive income for the year

5,493,203

2,618,461

Attributable to:

Equity holders of the parent

5,479,055

2,617,775

Non-controlling interest

14,148

686

The accompanying notes from 1 to 41 form an integral part of these consolidated financial statements.

Consolidated statement of financial position as at December 31, 2016

 

Notes

Dec. 31, 2016

Dec. 31, 2015

EGP Thousands

EGP Thousands

Assets

Cash and balances with central bank

13

10,522,040

9,848,954

Due from banks

14

58,011,034

21,002,305

Treasury bills and other governmental notes

15

39,177,184

22,130,170

Financial assets held for trading

16

2,445,134

5,848,377

Loans and advances to banks, net

17

159,651

38,443

Loans and advances to customers, net

18

85,224,148

56,797,576

Non-current assets held for sale

39

4,890,438

1,066,270

Derivative financial instruments

19

269,269

80,995

Financial investments

- Available for sale

21

5,447,291

46,289,075

- Held to maturity

21

53,924,936

9,261,220

Investments in associates

23

36,723

159,983

Other assets

24

5,434,563

4,789,291

Goodwill

40

-

217,078

Intangible assets

40

651,041

651,041

Deferred tax assets

10.2

181,308

258,157

Property and equipment

25

1,324,808

1,096,760

Total assets

267,699,568

179,535,695

Liabilities and equity

Liabilities

Due to banks

26

3,008,996

1,600,769

Due to customers

27

231,740,795

155,234,416

Non current liabilities held for sale

39

3,684,676

371,622

Derivative financial instruments

19

331,091

145,735

Other liabilities

29

4,268,774

3,164,106

Current Tax Liability

2,017,034

1,949,694

Long term loans

28

160,243

131,328

Provisions

30

1,514,057

861,761

Total liabilities

246,725,666

163,459,431

Equity

Issued and paid in capital

31

11,538,660

11,470,603

Reserves

32

3,448,737

149,480

Reserve for employee stock ownership plan (ESOP)

343,460

248,148

Retained earnings

5,509,967

4,160,601

Total equity attributable to equity holders of the parent

20,840,824

16,028,832

Non-controlling interest

133,078

47,432

Total equity

20,973,902

16,076,264

Total liabilities , equity and non-controlling interest

267,699,568

179,535,695

The accompanying notes from 1 to 41 form an integral part of these consolidated financial statements.

Consolidated statement of changes in shareholders' equity

Attributable to equity holders of the parents

Dec. 31, 2016

Issued and paid in capital

Reserve for employee stock ownership plan (ESOP)

Retained earnings

Reserves

Total

Non-controlling interest

Total equity

EGP Thousands

Beginning balance

9,081,734

177,766

 3,165,298

1,905,930

14,330,728

49,195

14,379,923

Profit for the year

-

-

4,227,687

-

4,227,687

686

4,228,373

Other comprehensive income

-

-

-

(1,609,226)

(1,609,226)

-

(1,609,226)

Total comprehensive income

-

-

4,227,687

(1,609,226)

2,618,461

686

2,619,147

Capital increase

2,388,869

-

-

(2,388,869)

-

-

-

Reserve for employee stock ownership plan (ESOP)

-

133,395

-

-

 133,395

-

133,395

Dividend

-

-

(1,053,752)

-

(1,053,752)

(1,081)

(1,054,833)

Transferred to reserves

-

(63,013)

(2,178,632)

2,241,645

-

-

-

Change during the year

-

 -

-

-

-

(1,368)

(1,368)

Balance at 31 December 2015

11,470,603

248,148

4,160,601

149,480

16,028,832

47,432

16,076,264

Profit for the year

-

-

5,448,248.0

-

5,448,248

 14,148

5,462,396

Other comprehensive income :

Net (Loss)/gain on available-for-sale financial assets

-

-

-

22,219

22,219

-

 22,219

Cumulative foreign currencies translation differences

-

-

-

8,588

8,588

-

8,588

Total comprehensive income

-

-

5,448,248

30,807

5,479,055

14,148

5,493,203

Capital increase

68,057

 -

-

 68,057

-

68,057

Reserve for employee stock ownership plan (ESOP)

-

 187,000

-

 -

187,000

-

187,000

Dividend

-

-

 (1,467,346.0)

-

(1,467,346)

(1,394)

(1,468,740)

Transferred to reserves

-

(91,688)

(3,176,762.0)

 3,268,450

-

-

-

Change during the year

-

-

545,226.0

-

545,226

 72,892

618,118

Balance at 31 December 2016

11,538,660

343,460

5,509,967

3,448,737

20,840,824

133,078

20,973,902

Consolidated cash flow statement for the year ended December 31, 2016

Notes

Dec. 31, 2016

Dec. 31, 2015

EGP Thousands

EGP Thousands

Cash flow from operating activities

Profit before income tax from continued operations

7,428,903

5,980,219

Profit before income tax from discontinued operations

40

158,040

71,161

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

288,057

197,988

Impairment charge for credit losses

892,874

1,682,439

Other provisions charges

150,847

135,866

Trading financial investments revaluation differences

(269,283)

353,590

Available for sale and held to maturity investments exchange revaluation differences

(2,219,961)

(96,638)

Goodwill impairment

217,078

-

Financial investments impairment charge

82,428

140,751

Utilization of other provisions

(3,696)

(17,242)

Other provisions no longer used

(78,405)

(505)

Exchange differences of other provisions

583,550

13,330

Profits from selling property, plant and equipment

(1,682)

(564)

Profits from selling financial investments

(35,193)

(163,270)

Profits (losses) from selling associates

90,447

(285,431)

Shares based payments

187,000

133,395

Impairment (Released) charges of associates

(131,799)

(27,829)

Associates financial investments revaluation differences

683

1,048

Operating profits before changes in operating assets and liabilities

7,339,888

8,118,308

Net decrease (increase) in assets and liabilities

Due from banks

264,072

(13,346,479)

Treasury bills and other governmental notes

(16,057,258)

5,497,825

Trading financial assets

3,672,526

(2,439,249)

Derivative financial instruments

(2,918)

(20,247)

Loans and advances to banks and customers

(29,440,654)

(9,714,737)

Other assets

(4,450,111)

(1,273,556)

Due to banks

1,408,227

469,384

Due to customers

76,506,379

33,259,457

Income tax obligations paid

(1,949,694)

(1,814,609)

Other liabilities

4,354,673

15,319

Net cash provided from operating activities

41,645,130

18,751,416

Cash flow from investing activities

Payment for purchase of subsidiary and associates

(12,036)

(868,119)

Proceeds from selling subsidiary and associates

176,161

334,451

Payment for purchases of property, plant, equipment and branches constructions

(560,631)

(304,401)

Proceeds from redemption of held to maturity financial investments

4,094

3,919,074

Payment for purchases of held to maturity financial investments

(44,667,810)

(4,019,548)

Payment for purchases of available for sale financial investments

(3,334,122)

(25,392,460)

Proceeds from selling available for sale financial investments

46,370,851

5,315,438

Proceeds (payments) from real estate investments

(2,989)

884,094

Goodwill impairment

-

217,078

Intangible Assets

-

651,041

Net cash used in investing activities

(2,026,482)

(19,263,352)

Cash flow from financing activities

Increase (decrease) in long term loans

28,915

(111,550)

Dividend paid

(1,463,450)

(1,563,646)

Capital increase

68,057

94,748

Payment related to finance lease

(12,380)

(12,380)

Net cash used in financing activities

(1,378,858)

(1,592,828)

Net increase (decrease) in cash and cash equivalent during the year

38,239,790

(2,104,764)

Beginning balance of cash and cash equivalent

14,435,901

16,540,665

Cash and cash equivalent at the end of the year

52,675,691

14,435,901

Cash and cash equivalent comprise:

Cash and balances with central bank

10,522,040

9,848,954

Due from banks

58,011,034

21,002,305

Treasury bills and other governmental notes

39,177,184

22,130,170

Obligatory reserve balance with CBE

(5,438,235)

(8,268,202)

Due from banks with maturities more than three months

(11,408,904)

(13,664,965)

Treasury bills with maturity more than three months

(38,187,428)

(16,612,361)

Total cash and cash equivalent

52,675,691

14,435,901

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/6999B_-2017-4-5.pdf

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR OKPDKQBKDDQK
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.